Redacción Alabrent
Kodak has been a trusted partner in manufacturing unregulated key starting materials (KSMs) for pharmaceutical applications for years. Kodak supplies KSMs to leading US and multinational contract development and manufacturing organizations (CDMOs). As part of its business expansion, Kodak is investing significantly to establish a state-of-the-art manufacturing facility for FDA-regulated Class I and Class II pharma products, including healthcare reagents for testing and medical treatment of patients, at Eastman Business Park in Rochester, N.Y. The new Kodak cGMP (Current Good Manufacturing Practice) plant will ensure consistent quality and a secure, reliable domestic supply chain for research institutions, CDMOs, and healthcare providers.”We are excited to announce that our ambitious project to expand our pharmaceutical business, which presents Kodak with long-term growth opportunities, has been honored with a prestigious Gold Stevie Award,” commented Jim Continenza, Executive Chairman and CEO of Kodak. “This award not only recognizes our commitment to bringing more manufacturing back to the United States but also highlights our efforts to ensure a reliable supply for the domestic healthcare sector.”
In addition to receiving a Gold accolade, Kodak was awarded a Bronze Stevie Award this year in the “Company of the Year – Manufacturing – Large” category. The company was recognized for its successful initiatives aimed at achieving leadership in industrial manufacturing within high-growth segments of its Print and Advanced Materials & Chemicals businesses.
The American Business Awards are the USA’s premier business awards program. All organizations operating in the USA are eligible to submit nominations – public and private, for-profit and non-profit, large and small. More than 250 professionals worldwide participated in the judging process to select this year’s Stevie Award winners. In 2024, Kodak was the proud winner of a Gold Stevie® Award in the “Best Business Technology Pivot” category.